{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:43:23Z","timestamp":1775637803999,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ygyno.2014.03.018","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T08:00:46Z","timestamp":1395129646000},"page":"542-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve"],"prefix":"10.1016","volume":"133","author":[{"given":"Suzanne M.E.","family":"van Cromvoirt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris M.G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orla M.","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.03.018_bb0005","series-title":"Green-top Guideline No. 38","article-title":"The management of gestational trophoblastic disease","author":"Royal College of Obstetricians and Gynaecologists","year":"2010"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2014.03.018_bb0010","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/S0020-7292(12)60026-5","article-title":"Trophoblastic disease. FIGO cancer report 2012","volume":"119","author":"Ngan","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.ygyno.2014.03.018_bb0015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-0528.2007.01320.x","article-title":"Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic","volume":"114","author":"Sebire","year":"2007","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ygyno.2014.03.018_bb0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2005.01.015","article-title":"The impact of molar pregnancy on psychological symptomatology","volume":"97","author":"Petersen","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"3 Pt 1","key":"10.1016\/j.ygyno.2014.03.018_bb0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9378(12)90820-0","article-title":"Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression disease by means of a normal human chorionic gonadotropin regression curve","volume":"168","author":"Yedema","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.03.018_bb0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/gyno.1998.5210","article-title":"Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles","volume":"71","author":"Shigematsu","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.03.018_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0090-8258(88)90150-3","article-title":"Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia","volume":"29","author":"Rotmensch","year":"1988","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.03.018_bb0040","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1048-891X.2004.14538.x","article-title":"Is normal beta-hCG regression curve helpful in the diagnosis of persistent trophoblastic disease?","volume":"14","author":"Behtash","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.03.018_bb0045","series-title":"Klinisch-chemische referentiewaarden in de zwangerschap","author":"Steegers","year":"1999"},{"issue":"8","key":"10.1016\/j.ygyno.2014.03.018_bb0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.1449","article-title":"Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control","volume":"5","author":"Kuuranne","year":"2013","journal-title":"Drug Test Analysis"},{"issue":"6","key":"10.1016\/j.ygyno.2014.03.018_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.03.018_bb0060","author":"Oncology"},{"issue":"41","key":"10.1016\/j.ygyno.2014.03.018_bb0065","first-page":"2219","article-title":"Trofoblastziekten","volume":"152","author":"ten Kate-Booij","year":"2008","journal-title":"Ned Tijdschr Geneeskd"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814002546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814002546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T21:20:23Z","timestamp":1538774423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814002546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090825814002546"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.03.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}